FLT3 Inhib Generic Drug

So, Gilteritinib is this FLT3 inhibitor that’s used for treating AML that comes back or doesn’t respond to treatment, especially in people who have these FLT3 mutations. It works by blocking this FLT3 kinase, which is a protein that makes leukemia cells grow. You can get it as 40 mg tablets, and the usual dose is 120 mg, taken once a day.

The tablets come in bottles with 90 of them. Gilteritinib’s main ingredient is made to go after this FLT3 tyrosine kinase, which often gets changed in AML and helps cancer cells keep growing. By stopping the kinase from working, gilteritinib can help keep the cancer cells from growing out of control.

There might be some side effects like anemia, low platelets, feeling queasy, and the runs. The doc might need to tweak the dose depending on how each person handles it and if they get any bad side effects.